Impaired lung function in individuals chronically exposed to biomass combustion

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSILVA, Luiz Fernando Ferraz da
dc.contributor.authorSALDIVA, Silvia Regina Dias Medici
dc.contributor.authorSALDIVA, Paulo Hilario Nascimento
dc.contributor.authorDOLHNIKOFF, Marisa
dc.contributor.groupauthorBandeira Cient Project
dc.date.accessioned2013-07-30T15:15:06Z
dc.date.available2013-07-30T15:15:06Z
dc.date.issued2012
dc.description.abstractBackground: The use of biomass for cooking and heating is considered an important factor associated with respiratory diseases. However, few studies evaluate the amount of particulate matter less than 2.5 mu in diameter (PM2.5), symptoms and lung function in the same population. Objectives: To evaluate the respiratory effects of biomass combustion and compare the results with those of individuals from the same community in Brazil using liquefied petroleum gas (Gas). Methods: 1402 individuals in 260 residences were divided into three groups according to exposure (Gas, Indoor-Biomass, Outside-Biomass). Respiratory symptoms were assessed using questionnaires. Reflectance of paper filters was used to assess particulate matter exposure. In 48 residences the amount of PM2.5 was also quantified. Pulmonary function tests were performed in 120 individuals. Results: Reflectance index correlated directly with PM2.5 (r=0.92) and was used to estimate exposure (ePM2.5). There was a significant increase in ePM2.5 in Indoor-Biomass and Outside-Biomass, compared to Gas. There was a significantly increased odds ratio (OR) for cough, wheezing and dyspnea in adults exposed to Indoor-Biomass (OR=2.93, 2.33, 2.59, respectively) and Outside-Biomass (OR=1.78, 1.78, 1.80, respectively) compared to Gas. Pulmonary function tests revealed both Non-Smoker-Biomass and Smoker-Gas individuals to have decreased %predicted-forced expiratory volume in the first second (FEV1) and FEV1/forced vital capacity (FVC) as compared to Non-Smoker-Gas. Pulmonary function tests data was inversely correlated with duration and ePM2.5. The prevalence of airway obstruction was 20% in both Non-Smoker-Biomass and Smoker-Gas subjects. Conclusion: Chronic exposure to biomass combustion is associated with increased prevalence of respiratory symptoms, reduced lung function and development of chronic obstructive pulmonary disease. These effects are associated with the duration and magnitude of exposure and are exacerbated by tobacco smoke.
dc.description.indexMEDLINE
dc.description.sponsorshipFAPESP
dc.description.sponsorship[FMUSP-HC/LIMs]
dc.description.sponsorshipCNPq
dc.identifier.citationENVIRONMENTAL RESEARCH, v.112, p.111-117, 2012
dc.identifier.doi10.1016/j.envres.2011.10.012
dc.identifier.issn0013-9351
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1007
dc.language.isoeng
dc.publisherACADEMIC PRESS INC ELSEVIER SCIENCE
dc.relation.ispartofEnvironmental Research
dc.rightsrestrictedAccess
dc.rights.holderCopyright ACADEMIC PRESS INC ELSEVIER SCIENCE
dc.subjectBiomass
dc.subjectLung function
dc.subjectChronic obstructive pulmonary disease
dc.subjectParticulate matter
dc.subject.otherindoor air-pollution
dc.subject.otherrespiratory symptoms
dc.subject.otherdeveloping-countries
dc.subject.otherpulmonary-disease
dc.subject.otherpassive smoking
dc.subject.othermexican women
dc.subject.otherwood smoke
dc.subject.otherchildren
dc.subject.otherhealth
dc.subject.otherrisk
dc.subject.wosEnvironmental Sciences
dc.subject.wosPublic, Environmental & Occupational Health
dc.titleImpaired lung function in individuals chronically exposed to biomass combustion
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalSALDIVA, Silvia Regina Dias Medici:State Hlth Secretariat, Hlth Inst, Sao Paulo, Brazil
hcfmusp.citation.scopus52
hcfmusp.contributor.author-fmusphcLUIZ FERNANDO FERRAZ DA SILVA
hcfmusp.contributor.author-fmusphcPAULO HILARIO NASCIMENTO SALDIVA
hcfmusp.contributor.author-fmusphcMARISA DOLHNIKOFF
hcfmusp.description.beginpage111
hcfmusp.description.endpage117
hcfmusp.description.volume112
hcfmusp.lim.ref2012
hcfmusp.origemWOS
hcfmusp.origem.pubmed22136759
hcfmusp.origem.scopus2-s2.0-84856229474
hcfmusp.origem.wosWOS:000299804800014
hcfmusp.publisher.citySAN DIEGO
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceBrostrom E.B., 2009, RESP MED
hcfmusp.relation.referenceBruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078
hcfmusp.relation.referenceChen RL, 2008, LANCET, V371, P201, DOI 10.1016/S0140-6736(08)60126-9
hcfmusp.relation.referenceCOTES JE, 1987, LANCET, V2, P1028
hcfmusp.relation.referenceDennekamp M, 2010, EPIDEMIOLOGY, V21, P494, DOI 10.1097/EDE.0b013e3181e093db
hcfmusp.relation.referenceDutt D, 1996, NATL MED J INDIA, V9, P113
hcfmusp.relation.referenceEkici A, 2005, ENVIRON RES, V99, P93, DOI 10.1016/j.envres.2005.01.004
hcfmusp.relation.referenceEllegard A, 1996, ENVIRON HEALTH PERSP, V104, P980, DOI 10.2307/3433146
hcfmusp.relation.referenceEllegard A, 1997, ENVIRON RES, V75, P12, DOI 10.1006/enrs.1997.3771
hcfmusp.relation.referenceEzzati M, 2001, ENVIRON HEALTH PERSP, V109, P481, DOI 10.2307/3454706
hcfmusp.relation.referenceJin Y, 2006, SOC SCI MED, V62, P3161, DOI 10.1016/j.socscimed.2005.11.029
hcfmusp.relation.referenceJohnson T, 2004, J EXPO ANAL ENV EPID, V14, P1, DOI 10.1038/sj.jea.7500294
hcfmusp.relation.referenceKiraz K, 2003, CLIN INVEST MED, V26, P243
hcfmusp.relation.referenceKurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644
hcfmusp.relation.referenceLiu Y, 2008, INT J TUBERC LUNG D, V12, P115
hcfmusp.relation.referenceSmith KR, 2003, INT J HYG ENVIR HEAL, V206, P279, DOI 10.1078/1438-4639-00224
hcfmusp.relation.referenceMenezes AMB, 2007, LANCET, V370, P716, DOI 10.1016/S0140-6736(07)61353-1
hcfmusp.relation.referenceMishra V, 2003, INT J EPIDEMIOL, V32, P847, DOI 10.1093/ije/dyg240
hcfmusp.relation.referenceMishra V, 1997, Natl Fam Health Surv Bull, P1
hcfmusp.relation.referencePadhy P.K., 2009, INHAL TOXICOL
hcfmusp.relation.referencePark SK, 2010, ENVIRON HEALTH PERSP, V118, P1406, DOI 10.1289/ehp.0901778
hcfmusp.relation.referencePauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256
hcfmusp.relation.referencePereira CA, 1992, J PNEUMOL, V18, P10
hcfmusp.relation.referencePerezPadilla R, 1996, AM J RESP CRIT CARE, V154, P701
hcfmusp.relation.referencePIERSON WE, 1989, WESTERN J MED, V151, P339
hcfmusp.relation.referencePolgar G, 1971, PULMONARY FUNCTION T
hcfmusp.relation.referenceQian Z, 2007, INDOOR AIR, V17, P135, DOI 10.1111/j.1600-0668.2006.00463.x
hcfmusp.relation.referenceRegalado J, 2006, AM J RESP CRIT CARE, V174, P901, DOI 10.1164/rccm.200503-479OC
hcfmusp.relation.referenceReid JS, 1998, J GEOPHYS RES-ATMOS, V103, P32031, DOI 10.1029/98JD00773
hcfmusp.relation.referenceRinne ST, 2007, AM J TROP MED HYG, V76, P585
hcfmusp.relation.referenceRinne ST, 2006, RESP MED, V100, P1208, DOI 10.1016/j.rmed.2005.10.020
hcfmusp.relation.referenceRumchev K, 2007, INDOOR AIR, V17, P468, DOI 10.1111/j.1600-0668.2007.00494.x
hcfmusp.relation.referenceSalvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9
hcfmusp.relation.referenceSANDOVAL J, 1993, CHEST, V103, P12, DOI 10.1378/chest.103.1.12
hcfmusp.relation.referenceSapkota A, 2008, INT J EPIDEMIOL, V37, P321, DOI 10.1093/ije/dym261
hcfmusp.relation.referenceSmith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518
hcfmusp.relation.referenceSmith KR, 2000, P NATL ACAD SCI USA, V97, P13286, DOI 10.1073/pnas.97.24.13286
hcfmusp.relation.referenceSmith-Sivertsen T, 2009, AM J EPIDEMIOL, V170, P211, DOI 10.1093/aje/kwp100
hcfmusp.relation.referenceSole D, 1998, J INVEST ALLERG CLIN, V8, P376
hcfmusp.relation.referenceSwiston JR, 2008, EUR RESPIR J, V32, P129, DOI 10.1183/09031936.00097707
hcfmusp.relation.referenceViegi G, 2004, INT J TUBERC LUNG D, V8, P1401
hcfmusp.relation.reference[WHO W.H. Organization], 2006, HOUS EN HLTH
hcfmusp.relation.reference[World Health Organization U.N. W.H. Organization], 2002, WHO USAID CONS HLTH
hcfmusp.relation.referenceZhou Y, 2009, EUR RESPIR J, V33, P509, DOI 10.1183/09031936.00084408
hcfmusp.remissive.sponsorshipCNPq
hcfmusp.remissive.sponsorshipFAPESP
hcfmusp.remissive.sponsorshipFMUSP-HC
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication0d4c5e63-ea43-4e35-9812-ff30ff292ef7
relation.isAuthorOfPublicationcb8ac601-f702-4f9a-9d07-7f10579e68d5
relation.isAuthorOfPublication136d0bce-36c6-4155-a113-4527576eba68
relation.isAuthorOfPublication.latestForDiscovery0d4c5e63-ea43-4e35-9812-ff30ff292ef7
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_SILVA_Impaired_lung_function_in_individuals_chronically_exposed_to_2012.PDF
Tamanho:
519.19 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)